Non-coding RNAs in the pathogenesis of COPD

Thorax

Volumn 70, Issue 8, 2015, Pages 782-791

  De Smet, Elise G ^a   Mestdagh, Pieter ^b   Vandesompele, Jo ^b   Brusselle, Guy G ^a   Bracke, Ken R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; LET 7C MICRORNA; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 101; MICRORNA 135B; MICRORNA 144; MICRORNA 146A; MICRORNA 15B; MICRORNA 199A-5P; MICRORNA 34B; MICRORNA 34C; MICRORNA 452; MICRORNA 638; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

AIRWAY OBSTRUCTION; AIRWAY REMODELING; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FLUID BALANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; LUNG EMPHYSEMA; MOUSE MODEL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; REVIEW; SMOKING; UPREGULATION; ANIMAL; GENETICS; HUMAN GENOME; LUNG; METABOLISM; MOUSE;

ANIMALS; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; LUNG; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, LONG NONCODING;

EID: 84940738036     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206560     Document Type: Review

References (82)

1. Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.
2. Ezzati M. Indoor air pollution and health in developing countries. Lancet 2005; 366:104-6.
3. Trupin L, Earnest G, San Pedro M, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003; 22:462-9.
4. Demedts IK, Morel-Montero A, Lebecque S., et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 2006; 61:196-201.
5. Fletcher C PR, Tinker C., Speizer FE. The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press, 1976.
6. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364:613-20.
7. Consortium EP, Bernstein BE, Birney E, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489:57-74.
8. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-73.
9. Friedman RC, Farh KK, Burge C.B., et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92-105.
10. Van Pottelberge GR, Mestdagh P, Bracke K.R., et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 183:898-906.
11. Bentwich I, Avniel A, Karov Y., et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005; 37:766-70.
12. Brosius J. Waste not, want not-transcript excess in multicellular eukaryotes. Trends Genet 2005; 21:287-8.
13. Tsai MC, Manor O, Wan Y., et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329:689-93.
14. Carrieri C, Cimatti L, Biagioli M., et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 2012; 491:454-7.
15. Wang J, Liu X, Wu H., et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38:5366-83.
16. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64:111-26.
17. Schembri F, Sridhar S, Perdomo C., et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA 2009; 106:2319-24.
18. Molina-Pinelo S, Pastor MD, Suarez R, et al. MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD. Eur Respir J 2014; 43:1740-9.
19. Schwanhausser B, Busse D, Li N., et al. Global quantification of mammalian gene expression control. Nature 2011; 473:337-42.
20. Spira A, Beane J, Shah V., et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 2004; 101:10143-8.
21. Beane J, Sebastiani P, Liu G., et al. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol 2007; 8:R201.
22. Izzotti A, Larghero P, Longobardi M., et al. Dose-responsiveness and persistence of microRNA expression alterations induced by cigarette smoke in mouse lung. Mutat Res 2011; 717:9-16.
23. Graff JW, Powers LS, Dickson A.M., et al. Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One 2012; 7:e44066.
24. Gross TJ, Powers LS, Boudreau R.L., et al. A microRNA processing defect in smokers' macrophages is linked to SUMOylation of the endonuclease DICER. J Biol Chem 2014; 289:12823-34.
25. Izzotti A, Calin GA, Arrigo P, et al. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 2009; 23:806-12.
26. Izzotti A, Calin GA, Steele V.E., et al. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J 2009; 23:3243-50.
27. Ezzie ME, Crawford M, Cho J.H., et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 2012; 67:122-31.
28. Chen Y, Gelfond JA, McManus L.M., et al. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 2009; 10:407.
29. Mestdagh P, Hartmann N, Baeriswyl L., et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods 2014; 11:809-15.
30. Van Peer G, Lefever S, Anckaert J., et al. miRBase Tracker: keeping track of microRNA annotation changes. Database (Oxford) 2014; 2014.
31. Martey CA, Pollock SJ, Turner C.K., et al. Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol 2004; 287: L981-91.
32. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58:585-8.
33. Sato T, Liu X, Nelson A., et al. Reduced miR-146a increases prostaglandin E (2) in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 2010; 182:1020-9.
34. Profita M, Sala A, Bonanno A., et al. Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products. Am J Physiol Lung Cell Mol Physiol 2010; 298:L261-9.
35. Huang SK, Wettlaufer SH, Chung J, et al. Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1. Am J Respir Cell Mol Biol 2008; 39:482-9.
36. Montuschi P KS, Carpagnano E., Culpitt S, et al. Exhaled prostaglandin E2: a new biomarker of airway inflammation in COPD. Am J Respir Crit Care Med 2000; 161 (A821).
37. Halappanavar S, Nikota J, Wu D., et al. IL-1 receptor regulates microRNA-135b expression in a negative feedback mechanism during cigarette smoke-induced inflammation. J Immunol 2013; 190:3679-86.
38. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009; 27:519-50.
39. Doz E, Noulin N, Boichot E., et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 2008; 180:1169-78.
40. Churg A, Zhou S, Wang X., et al. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 2009; 40:482-90.
41. D'Hulst AI, Bracke KR, Maes T, et al. Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J 2006; 28:102-12.
42. Barh D, Malhotra R, Ravi B., et al. MicroRNA let-7: an emerging next-generation cancer therapeutic. Curr Oncol 2010; 17:70-80.
43. Hassan F Jr GN, ME Ezzie, P Diaz, E, et al. Cigarette smoke regulates the expression of the CFTR chloride channel in bronchial epithelial cells. 2011.
44. Hassan F, Nuovo GJ, Crawford M, et al. MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung. PLoS One 2012; 7:e50837.
45. Zandvoort A, Postma DS, Jonker M.R., et al. Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. Eur Respir J 2006; 28:533-41.
46. Jorgensen E, Stinson A, Shan L., et al. Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer 2008; 8:229.
47. Dai BH, Geng L, Wang Y., et al. microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress. Cell Death Dis 2013; 4:e604.
48. Su SF, Chang YW, Andreu-Vieyra C, et al. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Oncogene 2013; 32:4694-701.
49. Hassan T, Carroll TP, Buckley P.G., et al. miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2014; 189:263-73.
50. Chatila WM, Criner GJ, Hancock W.W., et al. Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers. Clin Exp Immunol 2014; 177:341-52.
51. Gelb AF, Hogg JC, Muller N.L., et al. Contribution of emphysema and small airways in COPD. Chest 1996; 109:353-9.
52. Christenson SA, Brandsma CA, Campbell J.D., et al. miR-638 regulates gene expression networks associated with emphysematous lung destruction. Genome Med 2013; 5:114.
53. Zhu QY, Liu Q, Chen J.X., et al. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol 2010; 185:7435-42.
54. Mercer BA, Kolesnikova N, Sonett J., et al. Extracellular regulated kinase/mitogen activated protein kinase is up-regulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. J Biol Chem 2004; 279:17690-6.
55. Mercer BA, Wallace AM, Brinckerhoff C.E., et al. Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am J Respir Cell Mol Biol 2009; 40:4-12.
56. Hautamaki RD, Kobayashi DK, Senior R.M., et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277:2002-4.
57. Mizuno S, Bogaard HJ, Gomez-Arroyo J, et al. MicroRNA-199a-5p is associated with hypoxia-inducible factor-1alpha expression in lungs from patients with COPD. Chest 2012; 142:663-72.
58. Yasuo M, Mizuno S, Kraskauskas D., et al. Hypoxia inducible factor-1alpha in human emphysema lung tissue. Eur Respir J 2011; 37:775-83.
59. Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998; 12:149-62.
60. Tang K, Rossiter HB, Wagner P.D., et al. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol (1985) 2004; 97:1559-66; discussion 49.
61. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106:1311-9.
62. Brandsma CA, van den Berge M, Postma DS, et al. A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD. Thorax 2015; 70:21-32.
63. Savarimuthu Francis SM, Davidson MR, Tan M.E., et al. MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression. BMC Genomics 2014; 15:88.
64. Liu X, Sempere LF, Galimberti F, et al. Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res 2009; 15:1177-83.
65. Bouchie A. First microRNA mimic enters clinic. Nat Biotechnol 2013; 31:577.
66. Akbas F, Coskunpinar E, Aynaci E., et al. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res 2012; 38:286-94.
67. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010; 56:1733-41.
68. Xie L, Wu M, Lin H., et al. An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers. Mol Biosyst 2014; 10:1072-81.
69. Vencken SF, Greene CM, McKiernan PJ. Non-coding RNA as lung disease biomarkers. Thorax 2015; 70:501-3.
70. Pinkerton M, Chinchilli V, Banta E., et al. Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. J Allergy Clin Immunol 2013; 132:217-19.
71. Volders PJ, Helsens K, Wang X., et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res 2013; 41 (Database issue):D246-51.
72. Rinn JL, Kertesz M, Wang J.K., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129:1311-23.
73. Thai P, Statt S, Chen C.H., et al. Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J Respir Cell Mol Biol 2013; 49:204-11.
74. Beane J, Vick J, Schembri F., et al. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res (Phila) 2011; 4:803-17.
75. Hackett NR, Butler MW, Shaykhiev R, et al. RNA-Seq quantification of the human small airway epithelium transcriptome. BMC Genomics 2012; 13:82.
76. Itoh K, Wakabayashi N, Katoh Y., et al. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 2003; 8:379-91.
77. Rangasamy T, Cho CY, Thimmulappa R.K., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004; 114:1248-59.
78. Suzuki M, Betsuyaku T, Ito Y., et al. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2008; 39:673-82.
79. Cabili MN, Trapnell C, Goff L., et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011; 25:1915-27.
80. Bi H, Zhou J, Wu D., et al. Microarray analysis of long non-coding RNAs in COPD lung tissue. Inflamm Res 2015; 64:119-26.
81. Makita H, Nasuhara Y, Nagai K., et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007; 62:932-7.
82. Lin CW, Chang YL, Chang Y.C., et al. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun 2013; 4:1877.